Should I buy or sell Merus Labs International stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merus Labs International in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MSL shares. View MSL analyst ratings or view top-rated stocks .

When is Merus Labs International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our MSL earnings forecast .

How were Merus Labs International's earnings last quarter?

Merus Labs International Inc. (TSE:MSL) issued its earnings results on Wednesday, March, 27th. The specialty pharmaceutical company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.05.

Is Merus Labs International a good dividend stock?

Merus Labs International (TSE:MSL) pays an annual dividend of C$0.04 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Merus Labs International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merus Labs International investors own include Aurora Cannabis (ACB) , (MSLI) (MSLI) , ProMetic Life Sciences (PLI) , GuestLogix (GXI) , Royal Bank of Canada (RY) , Sierra Wireless (SWIR) , Village Farms International (VFF) and Wheaton Precious Metals (WPM) .

How do I buy shares of Merus Labs International?

Shares of MSL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:MSL

Merus Labs International (MSL) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free MSL Stock Alerts

Compare

Today's Range: N/A
50-Day Range: C$1.65
▼
C$1.65
52-Week Range: N/A

Volume: 21,975 shs
Average Volume: 476,228 shs
Market Capitalization: C$193.64 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Merus Labs International alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Merus Labs International Stock (TSE:MSL)

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

Click here to find out that this 8,788% cryptocurrency is.

MSL Stock News Headlines

April 18, 2024 | americanbankingnews.com

Merus Labs International (TSE:MSL) Earns "Buy" Rating from HC Wainwright

April 18, 2024 | americanbankingnews.com

Research Analysts Issue Forecasts for Merus Labs International Inc.'s Q1 2024 Earnings (TSE:MSL)

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

January 10, 2024 | ca.finance.yahoo.com

Albert Labs International Corp. (ABRT.CN)

September 1, 2023 | finance.yahoo.com

Defense Technologies International Corp. (DTII) Expands and Signs PT Lab Sistematika Indonesia as Distributor for SOUTHEAST ASIA

March 19, 2023 | newsweek.com

Global Biosafety Fears Grow Amid Rise in Labs Handling Dangerous Pathogens

February 22, 2023 | finance.yahoo.com

Laboratory Information System Global Market Report 2023

February 19, 2023 | chicago.suntimes.com

Palatine shocks Rolling Meadows, wins MSL title for the first time in 30 years

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

January 3, 2023 | finance.yahoo.com

Veterinary Reference Laboratory Global Market Report 2022: Ukraine-Russia War Impact

October 15, 2022 | markets.businessinsider.com

4 Analysts Have This to Say About Merus

September 18, 2022 | investing.com

Albert Labs International Corp (ABRT)

August 29, 2021 | msn.com

Football World Reacts To Bizarre Situation On ESPN

August 27, 2021 | msn.com

Girls Soccer: Worthington Christian Warriors plan to make strides under new coach

August 25, 2021 | msn.com

MSL and aizy spearhead new Danish CS:GO lineup

August 17, 2021 | msn.com

How to unlock a Boost Mobile phone and use it with other carriers

August 12, 2021 | msn.com

Roundup: Lancaster golfers place third in OCC; BC boys win MSL tourney

See More Headlines

Receive MSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merus Labs International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/27/2024
Today: 4/18/2024
Next Earnings (Estimated): 6/04/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Finance
Industry: Major Banks
Sub-Industry: N/A
Current Symbol: TSE:MSL
CUSIP: N/A
CIK: N/A
Web: www.meruslabs.com
Phone: +1-905-7260995
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 117,355,000
Free Float: N/A
Market Cap: C$193.64 million
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Michael S. Cloutier
Independent Chairman of the Board
Barry Fishman
Chief Executive Officer, Director
Michael Scott Bumby
Chief Financial Officer
Robert McLay
Vice President - Sales and Marketing
Frank Rotmann
Vice President and Head of European Operations
Robert Bloch M.D.
Director
Theresa Sheila Firestone
Independent Director
David D. Guebert CPA
Independent Director
Robert S. Pollock
Independent Director
Timothy G. Sorensen
Independent Director

Key Competitors

View All Competitors

MSL Stock Analysis - Frequently Asked Questions

Should I buy or sell Merus Labs International stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merus Labs International in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MSL shares.
View MSL analyst ratings or view top-rated stocks.
When is Merus Labs International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our MSL earnings forecast.
How were Merus Labs International's earnings last quarter?: Merus Labs International Inc. (TSE:MSL) issued its earnings results on Wednesday, March, 27th. The specialty pharmaceutical company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.05.
Is Merus Labs International a good dividend stock?: Merus Labs International (TSE:MSL) pays an annual dividend of C$0.04 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Merus Labs International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Merus Labs International investors own include Aurora Cannabis (ACB), (MSLI) (MSLI), ProMetic Life Sciences (PLI), GuestLogix (GXI), Royal Bank of Canada (RY), Sierra Wireless (SWIR), Village Farms International (VFF) and Wheaton Precious Metals (WPM).
How do I buy shares of Merus Labs International?: Shares of MSL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:MSL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Merus Labs International (MSL) Stock Price, News & Analysis

About Merus Labs International Stock (TSE:MSL)

MSL Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MSL Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info